GV and CA vaginal infections also induced nuclear factor (NF)-κB p65 activation and cyclooxygenase (COX)-2 expression, both of which were significantly reduced by the PAA treatment (p < 0.05; Fig. 3D) in a dose-dependent manner. The gene discussed is NFKB1; the disease is infective vaginitis.